These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24692842)

  • 1. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
    Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
    Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
    Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
    Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
    Wang S; Fang W
    Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
    Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
    Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
    World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.
    Zhang J; Chen N; Qi J; Zhou B; Qiu X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.
    Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A
    Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
    Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
    Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
    Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival.
    Geisler JP; Geisler HE; Manahan KJ; Miller GA; Wiemann MC; Zhou Z; Crabtree W
    Int J Gynecol Cancer; 2004; 14(1):133-7. PubMed ID: 14764041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
    Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
    Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
    Li D; Han Z; Liu J; Zhang X; Ren J; Yan L; Liu H; Xu Z
    Med Oncol; 2013 Dec; 30(4):702. PubMed ID: 23999841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
    Gabriel B; Hasenburg A; Waizenegger M; Orlowska-Volk M; Stickeler E; zur Hausen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1221-5. PubMed ID: 19823058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
    Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
    Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
    Uyama H; Tomita Y; Nakamura H; Nakamori S; Zhang B; Hoshida Y; Enomoto H; Okuda Y; Sakon M; Aozasa K; Kawase I; Hayashi N; Monden M
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6043-8. PubMed ID: 17062679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.